Michael Stubblefield, Avantor CEO

Dou­bling down on need for mR­NA vac­cines and mAbs, Avan­tor puts near­ly $3B in pumps and tub­ing com­pa­ny

Ac­qui­si­tion-hap­py man­u­fac­tur­er Avan­tor has po­si­tioned it­self at the front of the bat­tle against Covid-19, and Tues­day it made an­oth­er move to em­bed it­self deep­er in­to the on­go­ing pan­dem­ic re­sponse.

Penn­syl­va­nia-based Avan­tor ac­quired Mas­ter­flex from Antylia Sci­en­tif­ic for $2.7 bil­lion in an all-cash trans­ac­tion, the com­pa­ny an­nounced. The ac­qui­si­tion is Avan­tor’s 43rd over­all, as it has put more than $11 bil­lion in­to projects since 2011, the com­pa­ny said, with this trans­ac­tion aim­ing to be com­plet­ed in the fourth quar­ter.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.